The severity of newly diagnosed asthma patients and the result of initial 12 weeks treatment in China - INITIAL

Study identifier:NIS-RCN-XXX-2013/2

ClinicalTrials.gov identifier:NCT02143739

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

The severity of newly diagnosed asthma patients and the result of initial 12 weeks treatment in China.

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

4817

Study type

Observational

Age

18 Years +

Date

Study Start Date: 07 Jun 2014
Primary Completion Date: 15 Sept 2016
Study Completion Date: 15 Sept 2016

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -

Verification:

Verified 01 Sept 2017 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria